Tech Company Financing Transactions

Biomica Funding Round

Biomica closed a $20 million investment round on 4/27/2023. Investors included Evogene and Shanghai Healthcare Capital.

Transaction Overview

Company Name
Announced On
4/27/2023
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Investors

Evogene (Lead Investor)

Shanghai Healthcare Capital (Lead Investor)

Proceeds Purpose
The company intends to use the funds to complete its current BMC128 phase 1 immuno-oncology study and advance to phase 2 clinical trial, scale up and complete GMP production of BMC333 in preparation for a phase 1 clinical trial for the treatment of inflammatory bowel disease (IBD), as well as advance additional programs.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
13 Gad Feinstein st.
Park Rehovot, Undisclosed
IL
Email Address
Overview
Biomica is a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics for the treatment of immune-mediated and infectious diseases, with specific focus on Immuno-Oncology and GI related disorders. Biomica's discovery and development efforts are powered by PRISM (Predictive, high Resolution, Integrative Selection of Microbes) platform. PRISM is a proprietary metagenomics analysis platform for functional genomics profiling utilizing internal comprehensive databases.
Profile
Biomica LinkedIn Company Profile
Social Media
Biomica Company Twitter Account
Company News
Biomica News
Facebook
Biomica on Facebook
YouTube
Biomica on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Elran Haber
  Elran Haber LinkedIn Profile  Elran Haber Twitter Account  Elran Haber News  Elran Haber on Facebook
Chief Scientific Officer
Yehuda Ringel
  Yehuda Ringel LinkedIn Profile  Yehuda Ringel Twitter Account  Yehuda Ringel News  Yehuda Ringel on Facebook
VP - Finance
Yifat Zommer
  Yifat Zommer LinkedIn Profile  Yifat Zommer Twitter Account  Yifat Zommer News  Yifat Zommer on Facebook
VP - R & D
Shiri Meshner
  Shiri Meshner LinkedIn Profile  Shiri Meshner Twitter Account  Shiri Meshner News  Shiri Meshner on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/27/2023: Reviewpad venture capital transaction
Next: 4/27/2023: M3ter venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary